Literature DB >> 28569338

Clinical characteristics of juvenile idiopathic arthritis in an area of central Italy: a population-based study.

V Marzetti1, L Breda1, E Miulli1, F Filippetti2, C Mancini2, F Chiarelli1, E Altobelli3.   

Abstract

BACKGROUND: Juvenile idiopathic arthritis (JIA) is the most common chronic rheumatic disease in children and an important cause of short and long-term disability. In a recent systematic review of population based studies, the epidemiology of JIA is variable worldwide with incidence rates ranging between 1.6 and 23.0/100,000, and prevalence rates between 3.8 and 400.0/100,000. We investigate the incidence and describe the characteristics of juvenile idiopathic arthritis in the pediatric population of the central Italy, in the period 2000-2009.
METHODS: A retrospective study was conducted in the Marche region to identify patients with a diagnosis of juvenile idiopathic arthritis according to ILAR criteria, between January 1, 2000 and December 31, 2009. JIA was classified according to the ILAR criteria, that is, arthritis of unknown etiology that persisted for > 6 weeks with onset before the age of 16 years. The pooled global ascertainment of cases was estimated by capture-recapture methods and two independent information sources of ascertainment of new cases of JIA were considered.
RESULTS: We studied 151 patients (56 males, 37.1% and 95 females, 62.9%) meeting the ILAR criteria of juvenile idiopathic arthritis. Mean age at presentation was 6.8 ± 3.7 years for males and 6.0 ± 4.0 years for females (p=0.22). The overall incidence rate was 6.34 per 100,000/year (C.I. 6.26-7.35) and the total incidence rate increase from 2000-2009 was 8.16%. Oligoarthritis was the most common onset type (n=98, 65.0%) with 62.5% of ANA-positive patients in at least two determinations.
CONCLUSIONS: Our results indicate that juvenile idiopathic arthritis incidence rates in Italy are comparable to previous data from southern Europe, with a higher frequency of oligoarthritis. To the best of our knowledge, this is the first population-based epidemiological study carried out in Italy focusing on the incidence of juvenile idiopathic arthritis.

Entities:  

Keywords:  Children; Epidemiology; ILAR criteria; Juvenile idiopathic arthritis

Mesh:

Substances:

Year:  2017        PMID: 28569338     DOI: 10.7416/ai.2017.2152

Source DB:  PubMed          Journal:  Ann Ig        ISSN: 1120-9135


  5 in total

1.  Infliximab therapy and outcomes in patients with polyarticular juvenile idiopathic arthritis: a single-center study in China.

Authors:  Da-Wei Liu; Jiao-Jiao Chen; Xue-Mei Tang; Yu Zhang; Juan Zhou
Journal:  World J Pediatr       Date:  2019-10-14       Impact factor: 2.764

2.  Juvenile idiopathic arthritis in the biologic era: predictors of the disease progression and need for early introduction of biologic treatment.

Authors:  Panayiota Nalbanti; Florentia Kanakoudi-Tsakalidou; Maria Trachana; Polyxeni Pratsidou-Gertsi; Evangelia Farmaki; Panagiotis Bamidis; Fotios Papachristou
Journal:  Rheumatol Int       Date:  2018-05-29       Impact factor: 2.631

3.  [Clinical characteristics and biological treatment of adult patient with juvenile idiopathic arthritis].

Authors:  S X Wei; S J Li; Y Liu
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2020-12-18

Review 4.  Immunogenicity and safety of routine vaccines in children and adolescents with rheumatic diseases on immunosuppressive treatment - a systematic review.

Authors:  Michèle Keller; Laure F Pittet; Petra Zimmermann
Journal:  Eur J Pediatr       Date:  2021-12-22       Impact factor: 3.183

5.  Juvenile idiopathic arthritis in Jordan: single center experience.

Authors:  Raed M Alzyoud; Motasem O Alsuweiti; Heba Q Almaaitah; Bushra N Aladaileh; Mohammad K Alnoubani; Adel M Alwahadneh
Journal:  Pediatr Rheumatol Online J       Date:  2021-06-12       Impact factor: 3.054

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.